Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
10467-9 Beta-2-Microglobulin amyloid Ag PrThr Tiss Pt Ord Immune stain   ACTIVE Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain   MIN DefinitionDescription                   PATH   10467-9   Immune stain     Both       0 B2MG AL Ag Tiss Ql ImStn           Antigen; Antigens; B; B2 Microglob; b2-M; B2MG AL; Hematology; Heme; IHC; II; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Microglob; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified 2.56 1.0i                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
104670-5 PRKACA 19p13.1 gene rearrangement Find Tiss Pt Doc FISH   ACTIVE PRKACA 19p13.1 gene rearrangement in Tissue by FISH   ADD DefinitionDescription                   MOLPATH.REARRANGE   104670-5   FISH     Both       0 PRKACA 19p13.1 rearrange Tiss FISH       N   Document; Fibrolamellar Carcinoma; Finding; Findings; Fluorescent in situ hybridization; gene fusion; Gene Fusions; Gene Rearrangements; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Point in time; PRKACA 19p13.1 rearrange; Random; Tissue; Tissue, unspecified 2.78 2.78                       0
104671-3 Leukotriene B4 MCnc Plas Pt Qn LC/MS/MS   ACTIVE Leukotriene B4 [Mass/volume] in Plasma by LC/MS/MS   ADD DefinitionDescription     ng/mL             CHEM   104671-3   LC/MS/MS     Both       0 LTB4 Plas LC/MS/MS-mCnc       N   Chemistry; Level; LTB4; Mass Concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random 2.78 2.78               ng/mL       0
104672-1 IgD and IgE.monocloncal band observed Prid Ser Pt Nom Immunofixation   ACTIVE IgD and IgE.monocloncal band observed [Identifier] in Serum by Immunofixation   ADD DefinitionDescription                   CHEM   104672-1   Immunofixation     Both       0 IgD&IgE.Monoclon Band Obs Ser IFE       N   Bands; bnd; Chemistry; Identity or presence; IFE; Ifix; IgD&IgE.Monoclon Band Obs; Immune globulin D; Immune globulin E; Immunofixation electrophoresis; Immunoglobulin D; Immunoglobulin E; Nominal; Point in time; Random; Serum; SR 2.78 2.78                       0
104673-9 Diabetes mellitus type 1 autoimmune panel - Ser/Plas Pt -     ACTIVE Diabetes mellitus type 1 autoimmune panel - Serum or Plasma   ADD DefinitionDescription                   PANEL.SERO   104673-9         Order       0 Diabetes type 1 autoimn pnl SerPl       N   Diabetes type 1 autoimn pnl; DM; i; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.78 2.78   Panel                   0
104674-7 Methylphenidate MCnc Urine Pt Qn LC/MS/MS   ACTIVE Methylphenidate [Mass/volume] in Urine by LC/MS/MS   ADD DefinitionDescription     ng/mL             DRUG/TOX   104674-7   LC/MS/MS     Both       0 Me-phenidate Ur LC/MS/MS-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Me-phenidate; Point in time; QNT; Quan; Quant; Quantitative; Random; Ritalin; UA; UR; Urn 2.78 2.78               ng/mL       0
104675-4 Alpha-Phenyl-2-Piperidine acetate MCnc Urine Pt Qn LC/MS/MS   ACTIVE Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine by LC/MS/MS   ADD DefinitionDescription     ng/mL             DRUG/TOX   104675-4   LC/MS/MS     Both       0 PPAA Ur LC/MS/MS-mCnc       N   Acetic acid; Alfa; Alpha-phenyl-2-piperidine acetic acid; DRUG/TOXICOLOGY; Drugs; Ethanoate; Ethanoic acid; II; Level; Mass concentration; Methylphenidate metabolite; Phenylpiperidine acetate; Phenylpiperidine acetic acid; Point in time; PPAA; QNT; Quan; Quant; Quantitative; Random; Ritalinate; Ritalinic acid; UA; UR; Urn 2.78 2.78               ng/mL       0
104676-2 Methylphenidate & Alpha-Phenyl-2-Piperidine acetate panel - Urine Pt -     ACTIVE Methylphenidate and Alpha-Phenyl-2-Piperidine acetate panel - Urine   ADD DefinitionDescription                   PANEL.DRUG/TOX   104676-2         Order       0 Mthlphend & A-Phnl-2-Pprdn pnl Ur       N   Acetic acid; Alfa; Alpha-phenyl-2-piperidine acetic acid; DRUG/TOXICOLOGY; Drugs; Ethanoate; Ethanoic acid; II; Me-phenidate; Methylphenidate metabolite; Mthlphendt & Alph-Phnl-2-Piperdn act pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Phenylpiperidine acetate; Phenylpiperidine acetic acid; Pnl; Point in time; PPAA; Random; Ritalin; Ritalinate; Ritalinic acid; UA; UR; Urn 2.78 2.78   Panel                   0
104677-0 1,1-Dimethoxyhexadecane/palmitate MRto RBC Pt Qn     ACTIVE 1,1-Dimethoxyhexadecane (DMA 16:0)/palmitate (C16:0) [Mass Ratio] in Red Blood Cells   ADD DefinitionDescription     Ratio             CHEM   104677-0         Both       0 DMA 16:0/C16:0 RBC       N   C16:0; Chemistry; dimethyl acetal palmitic; DMA 16:0; DMA C16:0; Erythrocytes; Hexadecanoate; Hexadecanoic acid; i; Mass concentration ratio; Mass ratio; MCRto; Palmitic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles 2.78 2.78               {ratio}       0
104678-8 1,1-Dimethoxyoctadecane/octadecanoate MRto RBC Pt Qn     ACTIVE 1,1-Dimethoxyoctadecane (DMA 18:0)/Octadecanoate (C18:0) [Mass Ratio] in Red Blood Cells   ADD DefinitionDescription     Ratio             CHEM   104678-8         Both       0 DMA 18:0/C18:0 RBC       N   1-Heptadecanecarboxylic acid; C18:0; C18H36O2; Cetylacetic acid; Chemistry; DMA 18:0; DMA C18:0; Elaidate; Erythrocytes; i; Mass concentration ratio; Mass ratio; MCRto; Octadecanoic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Stearaldehyde, dimethyl acetal; Stearate; Stearic acid 2.78 2.78               {ratio}       0
104679-6 1,1-Dimethoxy-(9Z)octadecene MCnc RBC Pt Qn     ACTIVE 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Mass/volume] in Red Blood Cells   ADD DefinitionDescription     ug/mL             CHEM   104679-6         Both       0 DMA 18:1 RBC-mCnc       N   Chemistry; dimethyl acetal oleic; DMA 18:1; DMA C18:1; Erythrocytes; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles 2.78 2.78               ug/mL       0
10468-7 Calcitonin Ag PrThr Tiss Pt Ord Immune stain   ACTIVE Calcitonin Ag [Presence] in Tissue by Immune stain   MIN DefinitionDescription                   PATH   10468-7   Immune stain     Both       0 Calcit Ag Tiss Ql ImStn           Antigen; Antigens; CT; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Thyrocalcitonin; Tissue; Tissue, unspecified; Tumor marker 2.73 1.0i                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
104680-4 1,1-Dimethoxyoctadecane MCnc RBC Pt Qn     ACTIVE 1,1-Dimethoxyoctadecane (DMA 18:0) [Mass/volume] in Red Blood Cells   ADD DefinitionDescription     ug/mL             CHEM   104680-4         Both       0 DMA 18:0 RBC-mCnc       N   Chemistry; DMA 18:0; DMA C18:0; Erythrocytes; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Stearaldehyde, dimethyl acetal 2.78 2.78               ug/mL       0
104681-2 1,1-Dimethoxyhexadecane MCnc RBC Pt Qn     ACTIVE 1,1-Dimethoxyhexadecane (DMA 16:0) [Mass/volume] in Red Blood Cells   ADD DefinitionDescription     ug/mL             CHEM   104681-2         Both       0 DMA 16:0 RBC-mCnc       N   Chemistry; dimethyl acetal palmitic; DMA 16:0; DMA C16:0; Erythrocytes; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles 2.78 2.78               ug/mL       0
104682-0 1,1-Dimethoxyhexadecane MCnc Bld.dot Pt Qn     ACTIVE 1,1-Dimethoxyhexadecane (DMA 16:0) [Mass/volume] in DBS   ADD DefinitionDescription     ug/mL             CHEM   104682-0         Both       0 DMA 16:0 DBS-mCnc       N   Blood; Chemistry; DBS; dimethyl acetal palmitic; DMA 16:0; DMA C16:0; Dried blood spot; Filter paper; FP; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.78 2.78               ug/mL       0
104683-8 1,1-Dimethoxyoctadecane MCnc Bld.dot Pt Qn     ACTIVE 1,1-Dimethoxyoctadecane (DMA 18:0) [Mass/volume] in DBS   ADD DefinitionDescription     ug/mL             CHEM   104683-8         Both       0 DMA 18:0 DBS-mCnc       N   Blood; Chemistry; DBS; DMA 18:0; DMA C18:0; Dried blood spot; Filter paper; FP; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Stearaldehyde, dimethyl acetal; WB; Whole blood 2.78 2.78               ug/mL       0
104684-6 1,1-Dimethoxy-(9Z)octadecene MCnc Bld.dot Pt Qn     ACTIVE 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Mass/volume] in DBS   ADD DefinitionDescription     ug/mL             CHEM   104684-6         Both       0 DMA 18:1 DBS-mCnc       N   Blood; Chemistry; DBS; dimethyl acetal oleic; DMA 18:1; DMA C18:1; Dried blood spot; Filter paper; FP; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.78 2.78               ug/mL       0
104685-3 1,1-Dimethoxyhexadecane/palmitate MRto Bld.dot Pt Qn     ACTIVE 1,1-Dimethoxyhexadecane (DMA 16:0)/palmitate (C16:0) [Mass Ratio] in DBS   ADD DefinitionDescription     Ratio             CHEM   104685-3         Both       0 DMA 16:0/C16:0 DBS       N   Blood; C16:0; Chemistry; DBS; dimethyl acetal palmitic; DMA 16:0; DMA C16:0; Dried blood spot; Filter paper; FP; Hexadecanoate; Hexadecanoic acid; i; Mass concentration ratio; Mass ratio; MCRto; Palmitic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.78 2.78               {ratio}       0
104686-1 1,1-Dimethoxyoctadecane/octadecanoate MRto Bld.dot Pt Qn     ACTIVE 1,1-Dimethoxyoctadecane (DMA 18:0)/Octadecanoate (C18:0) [Mass Ratio] in DBS   ADD DefinitionDescription     Ratio             CHEM   104686-1         Both       0 DMA 18:0/C18:0 DBS       N   1-Heptadecanecarboxylic acid; Blood; C18:0; C18H36O2; Cetylacetic acid; Chemistry; DBS; DMA 18:0; DMA C18:0; Dried blood spot; Elaidate; Filter paper; FP; i; Mass concentration ratio; Mass ratio; MCRto; Octadecanoic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Stearaldehyde, dimethyl acetal; Stearate; Stearic acid; WB; Whole blood 2.78 2.78               {ratio}       0
104687-9 Dimethylacetal panel - Bld.dot Pt -     ACTIVE Dimethylacetal (DMA) panel - DBS   ADD DefinitionDescription                   PANEL.CHEM   104687-9         Order       0 DMA Pnl DBS       N   Blood; Chemistry; DBS; Dimethyl acetal; DMA Pnl; Dried blood spot; Filter paper; FP; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; WB; Whole blood 2.78 2.78   Panel                   0
104688-7 Measles, mumps, rubella and varicella-zoster virus Ab.IgG panel - Ser/Plas Pt -     ACTIVE Measles, mumps, rubella and varicella-zoster virus Ab.IgG panel - Serum or Plasma   ADD DefinitionDescription                   PANEL.MICRO   104688-7         Order       0 MMR & VZV pnl SerPl       N   Chicken pox; Chicken pox virus; Chickenpox; Herpes zoster; HHV-3; Human herpesvirus 3; Immune globulin G; Immunoglobulin G; Microbiology; MMR & VZV pnl; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Shingles; SR; VZ; VZV; Zoster 2.78 2.78   Panel                   0
104689-5 Egg White IgE Panel - Ser Pt -     ACTIVE Egg White IgE Panel - Serum   ADD DefinitionDescription                   PANEL.ALLERGY   104689-5         Order       0 Egg White IgE pnl Ser       N   Allergen; Allergens; ALLERGY TESTING; Egg White IgE pnl; f001; f1; Immune globulin E; Immunoglobulin E; Pan; PANEL.ALLERGY; Panl; Pnl; Point in time; Random; Serum; SR 2.78 2.78   Panel                   0
10469-5 Carcinoembryonic Ag PrThr Tiss Pt Ord Immune stain   ACTIVE Carcinoembryonic Ag [Presence] in Tissue by Immune stain   MIN DefinitionDescription                   PATH   10469-5   Immune stain     Both       0 CEA Tiss Ql ImStn           Antigen; Antigens; CEA; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified; Tumor marker 2.73 1.0i                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
104690-3 Bivalirudin MCnc PPP Pt Qn Chromo   ACTIVE Bivalirudin [Mass/volume] in Platelet poor plasma by Chromogenic method   ADD DefinitionDescription     ug/L             COAG   104690-3   Chromo     Both       0 Bivalirudin PPP Chro-mCnc       N   Angiomax; Angiox; Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Level; Mass concentration; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random 2.78 2.78               ug/L       0
104691-1 Clofazimine+Amikacin Susc Isolate Pt OrdQn MIC   ACTIVE Clofazimine+Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)   ADD DefinitionDescription     ug/mL             ABXBACT   104691-1   MIC     Both       0 Clofazimine + Amikacin Islt MIC       N   Amikin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; Clofazamine; Clofazimine + Amikacin; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.78 2.78                       0
104,672 results found